Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis

Matrix Metalloproteinases in Myasthenia Gravis

(2011) Geir Helgeland et al.   EUROPEAN NEUROLOGY

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia

(2010) Sarosh R. Irani et al.   BRAIN

Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome

(2010) Geir Helgeland et al.   JOURNAL OF NEUROIMMUNOLOGY

Clinical and immunological differences between early and late-onset myasthenia gravis in Japan

(2010) Shigeaki Suzuki et al.   JOURNAL OF NEUROIMMUNOLOGY

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

(2010) Meizan Lai et al.   LANCET NEUROLOGY

Ocular myasthenia: diagnostic and treatment recommendations and the evidence base

(2009) Uladzimir Luchanok et al.   CURRENT OPINION IN NEUROLOGY

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

(2009) Matthew N Meriggioli et al.   LANCET NEUROLOGY

Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis

(2008) Fredrik R. Romi et al.   JOURNAL OF NEUROIMMUNOLOGY

Clinical spectrum of voltage-gated potassium channel autoimmunity

(2008) K. M. Tan et al.   NEUROLOGY